Lactobacillus paracasei Strain ST11 Has No Effect on Rotavirus but Ameliorates the Outcome of Nonrotavirus Diarrhea in Children From Bangladesh

Background. Previous studies have shown that selected strains of lactobacilli that are administered orally result in a modest reduction of diarrhea duration. However, duration alone is not considered optimal for therapeutic evaluation of any agent in diarrhea. Objective. To examine the effect of a new probiotic, Lactobacillus paracasei strain ST11 (ST11), in acute childhood diarrhea by using evaluation criteria recommended by the World Health Organization. Methods. In a randomized, double-blind, placebo-controlled clinical trial, 230 male infants and young children, 4 to 24 months of age, presenting with diarrhea of <2 days' duration were admitted to the metabolic research ward of the International Centre for Diarrheal Disease Research, Bangladesh, and fed 1010 colony-forming units of lyophilized ST11 or placebo daily for 5 days. Stool output and frequency, oral rehydration solution intake, and excretion of rotavirus were monitored daily. Results. No effect of ST11 treatment on severe rotavirus diarrhea was observed. However, the probiotic treatment did significantly reduce cumulative stool output (225 ± 218 vs 381 ± 240 mL/kg), stool frequency (27.9 ± 17 vs 42.5 ± 26), and oral rehydration solution intake (180 ± 207 vs 331 ± 236 mL/kg) in children with less-severe nonrotavirus diarrhea compared with those receiving placebo treatment. A significantly higher proportion of nonrotavirus children receiving ST11 had their diarrhea resolve within 6 days of therapy (ST11 versus placebo: 76% vs 49%). Conclusions. ST11 has a clinically significant benefit in the management of children with nonrotavirus-induced diarrhea, but it is ineffective in those with rotavirus diarrhea.

[1]  S. Salminen,et al.  Oral bacteriotherapy for viral gastroenteritis , 1994, Digestive Diseases and Sciences.

[2]  A. Servin,et al.  Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. , 2004, FEMS microbiology reviews.

[3]  Gregor Reid,et al.  Potential Uses of Probiotics in Clinical Practice , 2003, Clinical Microbiology Reviews.

[4]  Elie. Metchnikoff The Prolongation of Life: Optimistic Studies , 2003 .

[5]  M. H. Zaki,et al.  Rotavirus‐specific subclass antibody and cytokine responses in Bangladeshi children with rotavirus diarrhoea , 2003, Journal of medical virology.

[6]  J. Vanderhoof,et al.  Limitations of Probiotic Therapy in Acute, Severe Dehydrating Diarrhea , 2003, Journal of pediatric gastroenterology and nutrition.

[7]  J. Mrukowicz,et al.  Probiotics in the Treatment and Prevention of Acute Infectious Diarrhea in Infants and Children: A Systematic Review of Published Randomized, Double-Blind, Placebo-Controlled Trials , 2001, Journal of pediatric gastroenterology and nutrition.

[8]  J. Mrukowicz,et al.  Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. , 2001, The Journal of pediatrics.

[9]  S. Sarker,et al.  Partially Hydrolyzed Guar Gum–Supplemented Oral Rehydration Solution in the Treatment of Acute Diarrhea in Children , 2000, Journal of pediatric gastroenterology and nutrition.

[10]  P. Auld,et al.  Objective ranking of fibrosis in standard histologic sections of human neonatal liver: applicability to alpha1-antitrypsin deficiency. , 2000, Journal of pediatric gastroenterology and nutrition.

[11]  T. Casswall Treatment of Enterotoxigenic and Enteropathogenic Escherichia coli-induced Diarrhoea in Children with Bovine Immunoglobulin Milk Concentrate from Hyperimmunized Cows: A Double-blind, Placebo-controlled, Clinical Trial , 2000, Scandinavian journal of gastroenterology.

[12]  H. Szajewska,et al.  Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. , 1998, Journal of pediatric gastroenterology and nutrition.

[13]  C. Kongkaew,et al.  Clinical evaluation of the addition of lyophilized, heat-killed Lactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute diarrhea in children. , 2000, Journal of pediatric gastroenterology and nutrition.

[14]  A. Faruque,et al.  Case-Control Study of Enteropathogens Associated with Childhood Diarrhea in Dhaka, Bangladesh , 1999, Journal of Clinical Microbiology.

[15]  R. Black,et al.  A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. , 1999, The Journal of pediatrics.

[16]  S. Sarker,et al.  Successful treatment of rotavirus diarrhea in children with immunoglobulin from immunized bovine colostrum. , 1998, The Pediatric infectious disease journal.

[17]  H. Mykkänen,et al.  Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. , 1997, Journal of pediatric gastroenterology and nutrition.

[18]  D. Mahalanabis,et al.  Hypo‐osmolar sucrose oral rehydration solutions in acute diarrhoea: a pilot study , 1996, Acta paediatrica.

[19]  M. Saxelin,et al.  Lactic Acid Bacteria in the Treatment of Acute Rotavirus Gastroenteritis , 1995, Journal of pediatric gastroenterology and nutrition.

[20]  L. Cuevas,et al.  Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan. , 1995, The Pediatric infectious disease journal.

[21]  H. Oshitani,et al.  Rotavirus gastro-enteritis in hospitalized children with acute diarrhoea in Zambia. , 1995, Annals of tropical paediatrics.

[22]  R. Yolken,et al.  Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus , 1994, The Lancet.

[23]  T. Koivula,et al.  A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. , 1991, Pediatrics.

[24]  K. Madison The Rational Use of Drugs in the Management of Acute Diarrhoea in Children , 1991 .

[25]  H. Necheles,et al.  Beneficial effects of administration of Lactobacillus acidophilus in diarrheal and other intestinal disorders. , 1961, The American journal of gastroenterology.